Feds Threaten to Pull ProAmatine for Lack of Postmarket Data - PharmExec.com (blog) PDF Print
PharmExec.com (blog)... patients,” stated Norman Stockbridge, director of the Division of Cardiovascular and Renal Drugs in the FDA's Center for Drug Evaluation and Research.

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.